APA način citiranja

Bharathy, N., Svalina, M. N., Settelmeyer, T. P., Cleary, M. M., Berlow, N. E., Airhart, S. D., . . . Keller, C. (2017). Preclinical testing of the glycogen synthase kinase-3β inhibitor tideglusib for rhabdomyosarcoma. Oncotarget.

Čikaški stil citiranja

Bharathy, Narendra, et al. "Preclinical Testing of the Glycogen Synthase Kinase-3β Inhibitor Tideglusib for Rhabdomyosarcoma." Oncotarget 2017.

MLA način citiranja

Bharathy, Narendra, et al. "Preclinical Testing of the Glycogen Synthase Kinase-3β Inhibitor Tideglusib for Rhabdomyosarcoma." Oncotarget 2017.